We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NNI:NYSENelnet, Inc. Analysis

Data as of 2026-05-29 - not real-time

$131.20

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Nelnet, Inc. posted a first‑quarter earnings miss, with revenue declining about 7% year‑over‑year and GAAP earnings per share falling short of consensus, prompting a 15.6% intraday sell‑off. Despite the disappointment, the company maintains strong profitability metrics—gross margin near 87% and operating margin above 21%—and trades at a price‑to‑earnings multiple that is materially below the credit‑services industry average, indicating a potential valuation edge. The dividend yield hovers around 1% with a very modest payout ratio, suggesting the dividend is sustainable, while the balance sheet is heavily leveraged, reflected in an exceptionally high debt‑to‑equity ratio.
Technical indicators show a neutral price trend, with the 20‑day and 200‑day moving averages converging near the current price, a bullish MACD histogram, and an RSI around the midpoint, but trading volume is on a downtrend and recent volatility has spiked above 45% over the past month. Overall, the stock appears undervalued on a value basis, but the combination of earnings weakness, high leverage, and elevated short‑term volatility tempers enthusiasm, leading to a cautious hold stance across horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Quarterly earnings miss and revenue decline
  • Technical support around $116.6 and bullish MACD histogram
  • Low dividend payout ratio supporting yield sustainability

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Valuation discount to industry P/E peers
  • High leverage increasing financial risk
  • Sustained dividend with low payout

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong operating margins and cash flow generation
  • Elevated debt‑to‑equity ratio limiting upside
  • Regulatory environment for student loan servicing

Key Metrics & Analysis

Financial Health

Revenue Growth-7.10%
Profit Margin25.34%
P/E Ratio11.4
ROE10.70%
ROA2.63%
Debt/Equity213.54
P/B Ratio1.3
Op. Cash Flow$404.9M
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI50.0
Support$116.62
Resistance$143.23
MA 20$130.54
MA 50$132.65
MA 200$130.89
MACDBullish
VolumeDecreasing
Fear & Greed Index93.66

Valuation

Target Price$135.00
Upside/Downside2.90%
GradeUndervalued
TypeValue
Dividend Yield0.99%

Risk Assessment

Beta0.47
Volatility45.20%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.